Precision BioSciences
DTIL
72 hedge funds and large institutions have $179M invested in Precision BioSciences in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.
183% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
14% more funds holding
Funds holding: 63 → 72 (+9)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
0.06% less ownership
Funds ownership: 1.46% → 1.4% (-0.06%)
39% less capital invested
Capital invested by funds: $291M → $179M (-$113M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$1.51M |
| 2 |
BlackRock
New York
|
+$968K |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$868K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$832K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$798K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$4.48M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.72M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.71M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$2.61M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.55M |
DTIL Hedge Fund Activity: Q3 2019 in Review
72 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2019, worth a combined $179M — down 39% from $291M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new DTIL positions and 6 closed out — a net gain of 11 holders — while 17 added to existing stakes and 17 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $1.51M. The largest seller was Franklin Resources, cutting an estimated $4.48M.
- 72 institutional investors held Precision BioSciences (DTIL) as of Q3 2019, up from 63 in Q2 2019.
- Funds reported $179M of Precision BioSciences stock for Q3 2019, down 39% quarter-over-quarter.
- 17 funds opened new Precision BioSciences positions in Q3 2019 and 6 closed out, a net change of +11 holders.
- The largest Precision BioSciences buyer in Q3 2019 was Victory Capital Management, an estimated $1.51M added.
- The largest Precision BioSciences seller in Q3 2019 was Franklin Resources, an estimated $4.48M sold.
Based on aggregated 13F filings for Q3 2019.